Hualan Biological Vaccine Inc. (SHE:301207)
China flag China · Delayed Price · Currency is CNY
19.55
+0.13 (0.67%)
Mar 10, 2026, 11:05 AM CST

Hualan Biological Vaccine Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2019 - 2017
Cash & Equivalents
854.14623.04640.98600.04131.56412.39
Upgrade
Short-Term Investments
687.181,145373.46130--
Upgrade
Trading Asset Securities
1,5341,4581,5991,419825.82452.86
Upgrade
Cash & Short-Term Investments
3,0763,2272,6132,149957.39865.25
Upgrade
Cash Growth
21.14%23.48%21.57%124.50%10.65%72.84%
Upgrade
Accounts Receivable
1,3481,4381,9901,7961,4391,530
Upgrade
Other Receivables
0.570.411.310.412.152.18
Upgrade
Receivables
1,3491,4382,4121,8561,4411,532
Upgrade
Inventory
269.42208.84173.47167.16107.4145.27
Upgrade
Other Current Assets
86103.1328.1820.2223.3122.86
Upgrade
Total Current Assets
4,7804,9775,2274,1932,5292,465
Upgrade
Property, Plant & Equipment
971.51,0711,1761,2871,351810.97
Upgrade
Long-Term Investments
-1,2041,2961,310356.3-
Upgrade
Other Intangible Assets
20.2920.8820.1320.7821.4322.08
Upgrade
Long-Term Deferred Tax Assets
204.76212.73217.97208.56182.9170.41
Upgrade
Long-Term Deferred Charges
27.8727.7927.9428.6933.3619.58
Upgrade
Other Long-Term Assets
1,17511.0530.6127.9848.93159.61
Upgrade
Total Assets
7,1797,5237,9957,0764,5233,648
Upgrade
Accounts Payable
73.3781.78116.76125.67185.5105.46
Upgrade
Accrued Expenses
-903.531,1551,050929.48956.07
Upgrade
Short-Term Debt
-300.18300.18300.18500.44200
Upgrade
Current Portion of Leases
----1.03-
Upgrade
Current Income Taxes Payable
6.26-50.819.2415.99154.44
Upgrade
Current Unearned Revenue
4.598.742.672.681.541.89
Upgrade
Other Current Liabilities
1,380169.960.6349.1338.1936.74
Upgrade
Total Current Liabilities
1,4641,4641,6861,5371,6721,455
Upgrade
Long-Term Leases
----0.81-
Upgrade
Long-Term Unearned Revenue
24.0127.1931.4235.6639.896
Upgrade
Long-Term Deferred Tax Liabilities
16.1618.815.226.412.50.28
Upgrade
Total Liabilities
1,5051,5101,7321,5791,7151,461
Upgrade
Common Stock
601.03601.03600.02400.01360360
Upgrade
Additional Paid-In Capital
2,9312,9262,9153,089879.79879.79
Upgrade
Retained Earnings
2,2492,5932,7482,0081,568947.34
Upgrade
Treasury Stock
-106.79-106.79----
Upgrade
Shareholders' Equity
5,6756,0136,2635,4972,8082,187
Upgrade
Total Liabilities & Equity
7,1797,5237,9957,0764,5233,648
Upgrade
Total Debt
-300.18300.18300.18502.27200
Upgrade
Net Cash (Debt)
3,0762,9262,3131,849455.12665.25
Upgrade
Net Cash Growth
37.38%26.53%25.07%306.31%-31.59%32.89%
Upgrade
Net Cash Per Share
5.174.893.843.130.841.23
Upgrade
Filing Date Shares Outstanding
595595600.02600.02600.02600.02
Upgrade
Total Common Shares Outstanding
595595600.02600.02540540
Upgrade
Working Capital
3,3163,5123,5412,656857.071,011
Upgrade
Book Value Per Share
9.5410.1110.449.165.204.05
Upgrade
Tangible Book Value
5,6555,9926,2435,4762,7872,165
Upgrade
Tangible Book Value Per Share
9.5010.0710.409.135.164.01
Upgrade
Buildings
-376.55376.55376.19375.5169.91
Upgrade
Machinery
-1,4961,4721,4501,388688.28
Upgrade
Construction In Progress
-6.723.233.26-315.55
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.